After 30 years of research, the treatment of bladder cancer may be about to change. Clinical trial results for a new drug, Urocidin, are promising, according to researchers.

If you've been taking Actos or Takeda for more than a year to control your type 2 diabetes, you will want to be in touch with your family physician or endocrinologist. A link with bladder cancer has been discovered.

Actos and Competact, two top-selling type 2 diabetes drugs, have been pulled off the markets in France and Germany following studies linking the medications to bladder cancer.

A new study indicates that men with Benign Prostate Enlargement (BPE) experiencing frequent night time bathroom visits may additinally have sleep apnea issues.

Brown University researchers have devised a blood test that can accurately detect biomolecular markers of bladder cancer.

Autoimmunity and cancer may be linked in certain forms of the autoimmune disease scleroderma, according to new research from Johns Hopkins University.